Clinical Feasibility of Ultrafast Contrast-Enhanced T1-Weighted 3D-EPI for Evaluating Intracranial Enhancing Lesions in Oncology Patients: Comparison with Standard 3D MPRAGE Sequence

^aFrom the Departments of Radiology (K.H.R., H.J.B., E.C., I.C.N.)
^bInternal Medicine (T.H.K.), Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
^cDepartment of Radiology (H.J.B.), Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Republic of Korea
^dDepartment of Neuroradiology (S.S.)
^eClinical Neuroscience (S.S., T.S.), Karolinska Institute, Stockholm, Sweden
^fMR Applied Science Laboratory Europe (T.S.), GE Healthcare, Stockholm, Sweden

Please address correspondence to Hye Jin Baek, MD, PhD, Department of Radiology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, 11 Samjeongja-ro, Seongsan-gu, Changwon 51472, Korea; e-mail:sartre81{at}gmail.com